BioAge Labs Forecast, price target & analysts
BioAge Labs Target price 2026 - Analyst rating & recommendation
BioAge Labs Classifications & Recommendation:
BioAge Labs Price Target
| Target Price | $12.24 |
| Price | $15.41 |
| Deviation |
20.57%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target BioAge Labs 2027 .
The average BioAge Labs target price is $12.24.
This is
20.57%
register free of charge
$15.75
2.21%
register free of charge
$9.09
41.01%
register free of charge
|
|
| A rating was issued by 9 analysts: 1 Analysts recommend BioAge Labs to buy, 4 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioAge Labs stock has an average upside potential 2027 of
20.57%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 7.20 |
7 Analysts have issued a sales forecast BioAge Labs 2025 . The average BioAge Labs sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an BioAge Labs EBITDA forecast 2025. The average BioAge Labs EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 BioAge Labs Analysts have issued a net profit forecast 2025. The average BioAge Labs net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.98 | -2.35 |
| 5.88% | 18.69% | |
| P/E | negative | |
| EV/Sales | 37.65 |
7 Analysts have issued a BioAge Labs forecast for earnings per share. The average BioAge Labs EPS is
This results in the following potential growth metrics and future valuations:
Current BioAge Labs Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 08 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 08 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 22 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
